Author(s): Santhosh S, R. Kamaraj

Email(s): santhoshpharmara003@gmail.com

DOI: 10.5958/0974-360X.2018.01028.4   

Address: Santhosh S, Dr. R. Kamaraj
Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur - 6030203, Kanchipuram, Tamilnadu, India.
*Corresponding Author

Published In:   Volume - 11,      Issue - 12,     Year - 2018


ABSTRACT:
Premarket approval application is not essential but 510(k) must submit to FDA to market medical device in the U.S for human use. To conclude or to determine the device is substantially equivalent to the device which is already marketed. After getting a 510(k) clearance immediately device can be marketed by submitter. In such case where already marketed device is changed in its safety or effectiveness it might affect the manufacturer and there is essential to file a 510(k) submission by manufacturer. Manufacturer should submit 510(k) to FDA in case of modifications or changes in use, chemical composition, design, energy source etc,.510(k) submission depends upon the comparison between the already marketed device and new device in the U.S, to ascertain whether the device is safety and effectiveness.2


Cite this article:
Santhosh S, R. Kamaraj. 510(k) Premarket Notification. Research J. Pharm. and Tech 2018; 11(12): 5675-5780. doi: 10.5958/0974-360X.2018.01028.4

Cite(Electronic):
Santhosh S, R. Kamaraj. 510(k) Premarket Notification. Research J. Pharm. and Tech 2018; 11(12): 5675-5780. doi: 10.5958/0974-360X.2018.01028.4   Available on: https://rjptonline.org/AbstractView.aspx?PID=2018-11-12-77


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available